Advertisements



Contrafect: A New Anti-Microbial Treatment Paradigm

Contrafect: A New Anti-Microbial Treatment Paradigm.....»»

Category: topSource: seekingalphaOct 11th, 2018

Tennessee governor approves law that bans transgender youth from getting gender-confirming hormone treatment

The new law is the latest anti-trans legislation in Tennessee that targets transgender people, as .....»»

Category: smallbizSource: nytMay 20th, 2021

Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

        - First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis' Anti-BCMA Agent for the Treatment of Multiple Myeloma - - On Track to Initiate AL102 Phase 2/3 Pivotal Trial for the Treatment of.....»»

Category: earningsSource: benzingaMay 14th, 2021

ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update

Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»

Category: earningsSource: benzingaMay 14th, 2021

Exclusive: Precigen"s CEO Breaks Down Biotech"s Oncology Platforms, Technology, Differentiators

Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics. read more.....»»

Category: blogSource: benzingaApr 6th, 2021

The Margin: The Fox News prime-time lineup, President Trump aren’t pushing hydroxychloroquine like they used to

Studies show the risks of taking the anti-malarial drug as a treatment for COVID-19......»»

Category: topSource: marketwatchApr 22nd, 2020

Anti-malarial drug Trump touted is linked to higher rates of death in VA coronavirus patients, study says

Rates of death in the groups treated with the drugs were worse than for those who received no treatment, and rates of patients on ventilators were similar, the study found......»»

Category: topSource: washpostApr 22nd, 2020

A treatment for the coronavirus would be priceless — and worth about 5,000 points in the Dow Jones Industrial Average

Positive, but only anecdotal, news about Gilead’s remdesivir anti-viral treatment pushed up stocks Friday. A highly successful treatment for the coronavirus would prompt a massive rally......»»

Category: topSource: marketwatchApr 17th, 2020

Benzinga Pro"s Top 5 Stocks To Watch For Fri., Apr. 17, 2020: GILD, NOK, INVH, THMO, LOGM

Today's 5 Stock Ideas:  Gilead (GILD) - Optimistic sentiment on the company's anti-viral COVID-19 treatment, remdesivir, is one of the top reasons the stock market is trading sharply higher read more.....»»

Category: blogSource: benzingaApr 17th, 2020

Media On "Jihad" Against Anti-Malaria COVID-19 Treatment Since Trump Endorsed Use: AG Barr

Media On 'Jihad' Against Anti-Malaria COVID-19 Treatment Since Tr.....»»

Category: blogSource: zerohedgeApr 9th, 2020

Facebook and Twitter blocked videos from Brazilian president Jair Bolsonaro for coronavirus misinformation

Andressa Anholete/Getty Images Facebook and Twitter have removed videos of Brazilian president Jair Bolsonaro endorsing the anti-malarial drug hydroxychloroquine as a COVID-19 treatment. Social media companies have been r.....»»

Category: topSource: businessinsiderMar 31st, 2020

Hospitals and doctors are wiping out supplies of an unproven coronavirus treatment

Anti-malarial drugs chloroquine and hydroxychloroquine are in high demand, despite lacking definitive evidence as an effective treatment for the coronavirus......»»

Category: smallbizSource: nytMar 20th, 2020

KU Cancer Center-invented drug could eliminate need for bladder removal

CicloMed LLC has expanded a clinical trial for an anti-cancer drug that could potentially transform the treatment of bladder cancer. Researchers at the University of Kansas Cancer Center and its Institute for Advancing Medical Innovation (IAMI) f.....»»

Category: topSource: bizjournalsDec 10th, 2019

The Agenda: MimiVax is a new local growth star, Kaleida is shifting beds and the Bills are (sort of) in the playoffs

MORNING LEAD MimiVax, a Buffalo company that is developing an anti-cancer immunotherapy for the treatment of glioblastoma brain tumors, has reached a deal with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. worth up to $148 million. .....»»

Category: topSource: bizjournalsNov 18th, 2019

Exelixis: Treatment Paradigm Winds See Cabometyx Falling Flat, For Now

Exelixis: Treatment Paradigm Winds See Cabometyx Falling Flat, For Now.....»»

Category: topSource: seekingalphaNov 12th, 2019

T2 Biosystems to share pipeline data at World Anti-Microbial Resistance Congress

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 7th, 2019

Amazon in deal with German watchdog to overhaul marketplace terms

Amazon has reached a deal with Germany's anti-trust authority to overhaul its terms of service for third-party merchants, who had complained of unfair treatment when selling through the world's biggest online retailer......»»

Category: topSource: reutersJul 16th, 2019

ContraFect: A Buy For Their Next Generation Anti-Infection Proteins

ContraFect: A Buy For Their Next Generation Anti-Infection Proteins.....»»

Category: topSource: seekingalphaJun 18th, 2018

Exclusive: Credit Suisse creates new anti-sexual harassment role

Credit Suisse has carved out a new role to lead its handling of sexual harassment claims and examine group-wide policies, as Switzerland's second-biggest bank seeks to boost equal opportunities and create a fair treatment environment......»»

Category: topSource: reutersJul 6th, 2018

The FDA Approves Merck"s Anti-HIV-1 Drugs

Merck's products represent a treatment option for chronically infected adult patients in the USRelated Stocks: MRK,.....»»

Category: smallbizSource: nytAug 31st, 2018

Teva"s (TEVA) Migraine Drug Ajovy Receives FDA Approval

Teva Pharmaceutical's (TEVA) anti-CGRP drug, Ajovy, gets FDA nod as a preventive treatment of migraine in adult patients. .....»»

Category: worldSource: nytSep 17th, 2018